Table 4.

Predictors of Vancomycin-Associated Nephrotoxicity by Multivariate Analysis^*

Parameter	Adjusted OR (95% CI)	p value
Clinical area general medicine	2.57 (1.01–6.58)	0.048
Duration of vancomycin treatment (weeks)	1.35 (1.04–1.76)	0.025
Concurrent use of ACE inhibitor or ARB	0.13 (0.02–1.00)	0.049

ACE = angiotensin-converting-enzyme, ARB = angiotensin receptor blocker, CI = confidence interval, OR = odds ratio.

^*Variables in the multivariate analysis were controlled for baseline serum creatinine.